These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3898750)
1. Studies of human natural killer cytotoxic factor (NKCF): characterization and analysis of its mode of action. Ortaldo JR; Blanca I; Herberman RB Adv Exp Med Biol; 1985; 184():203-20. PubMed ID: 3898750 [TBL] [Abstract][Full Text] [Related]
2. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells. Blanca I; Herberman RB; Ortaldo JR Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671 [TBL] [Abstract][Full Text] [Related]
3. Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF. Ortaldo JR; Winkler-Pickett R; Morgan AC; Woodhouse C; Kantor R; Reynolds CW J Immunol; 1987 Nov; 139(9):3159-65. PubMed ID: 3668253 [TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors. Wright SC; Wilbur SM; Bonavida B Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581 [TBL] [Abstract][Full Text] [Related]
5. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility. Uchida A; Vánky F; Klein E J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505 [TBL] [Abstract][Full Text] [Related]
6. Analysis of rat natural killer cytotoxic factor (NKCF): mechanism of action and relationship to other cytotoxic/cytostatic factors. Winkler-Pickett RT; Young HA; Kuta A; Ortaldo JR Cell Immunol; 1991 Jun; 135(1):42-54. PubMed ID: 2018982 [TBL] [Abstract][Full Text] [Related]
7. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D. Uchida A; Klein E Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288 [TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor. Wright SC; Bonavida B J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288 [TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related]
10. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing. Farram E; Targan SR J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733 [TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines. Wright SC; Bonavida B J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292 [TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909 [TBL] [Abstract][Full Text] [Related]
13. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells. Bonavida B; Wright SC J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135 [TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of the human natural killer cell lethal hit: analysis of the mechanism of protease inhibition of the lethal hit. Hiserodt JC; Britvan L; Targan SR J Immunol; 1983 Dec; 131(6):2705-9. PubMed ID: 6358352 [TBL] [Abstract][Full Text] [Related]
15. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586 [TBL] [Abstract][Full Text] [Related]
16. Release of natural killer cytotoxic factor (NKCF) from canine natural killer (NK) cells stimulated with cytoplasmic membrane of target cells. Nakada Y; Tsukatani Y; Kosaka T; Miyamori M; Kuwabara M; Tanaka S; Koide F J Vet Med Sci; 1995 Feb; 57(1):165-7. PubMed ID: 7756413 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes. Shanahan F; Niederlehner A; MacDermott RP; Stenson WF; Kane MG; Targan S Immunopharmacology; 1986 Apr; 11(2):111-8. PubMed ID: 2872187 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells. Bonavida B; Katz J; Hoshino T Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275 [TBL] [Abstract][Full Text] [Related]
19. Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity. Graves SS; Bramhall J; Bonavida B J Immunol; 1986 Sep; 137(6):1977-84. PubMed ID: 2427588 [TBL] [Abstract][Full Text] [Related]
20. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification. Roozemond RC; Mevissen M; Urli DC; Bonavida B J Immunol; 1987 Sep; 139(5):1739-46. PubMed ID: 3624869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]